Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway
Tóm tắt
Từ khóa
Tài liệu tham khảo
Singenthaler, 1986, Aminoglycoside antibiotics in infectious diseases, Am J Med, 80, 2, 10.1016/0002-9343(86)90473-0
Martinez-Salgado, 2007, Glomerular nephrotoxicity of aminoglycosides, Toxicol Appl Pharmacol, 223, 86, 10.1016/j.taap.2007.05.004
Rodriguez-Barbero, 2000, Potential use of isolated glomeruli and cultured mesangial cells as in vitro models to assess nephrotoxicity, Cell Biol Toxicol, 16, 143, 10.1023/A:1007683320660
Martinez-Salgado, 2004, Gentamicin treatment induces simultaneous mesangial proliferation and apoptosis in rats, Kidney Int, 65, 2161, 10.1111/j.1523-1755.2004.00642.x
Hall, 2007, The not so ‘Mighty Chondrion’: emergence of renal diseases due to mitochondrial dysfunction, Nephron Physiol, 105, 1, 10.1159/000096860
Sanz, 2008, Mechanisms of renal apoptosis in health and disease, J Am Soc Nephrol, 19, 1634, 10.1681/ASN.2007121336
Simmons, 1980, Inhibitory effects of gentamicin on renal mitochondrial oxidative phosphorylation, J Pharmacol Exp Ther, 214, 709
Kiritoshi, 2003, Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy, Diabetes, 52, 2570, 10.2337/diabetes.52.10.2570
Plotnikov, 2007, The role of mitochondria in oxidative and nitrosative stress during ischemia/reperfusion in the rat kidney, Kidney Int, 72, 1493, 10.1038/sj.ki.5002568
Baliga, 1999, Oxidant mechanisms in toxic acute renal failure, Drug Metab Rev, 31, 971, 10.1081/DMR-100101947
Forbes, 2008, Oxidative stress as a major culprit in kidney disease in diabetes, Diabetes, 57, 1446, 10.2337/db08-0057
Rodriguez-Barbero, 1997, Involvement of platelet-activating factor in gentamicin nephrotoxicity in rats, Exp Nephrol, 5, 47
Pannu, 2008, An overview of drug-induced acute kidney injury, Crit Care Med, 36, S216, 10.1097/CCM.0b013e318168e375
Martinez-Salgado, 2002, Involvement of oxygen reactive species on gentamicin-induced mesangial cell activation, Kidney Int, 62, 1682, 10.1046/j.1523-1755.2002.00635.x
Servais, 2008, Renal cell apoptosis induced by nephrotoxic drugs: cellular and molecular mechanisms, and potential approaches to modulation, Apoptosis, 13, 11, 10.1007/s10495-007-0151-z
Walker, 1987, Gentamicin enhanced production of hydrogen peroxide by renal cortical mitochondria, Am J Physiol, 253, C495, 10.1152/ajpcell.1987.253.4.C495
Morales, 2002, Protective effect of trans-resveratrol on gentamicin-induced nephrotoxicity, Antioxid Redox Signal, 4, 893, 10.1089/152308602762197434
Maldonado, 2003, Antioxydant S-allylcysteine prevents gentamicin-induced oxidative stress and renal damage, Free Radic Biol Med, 35, 317, 10.1016/S0891-5849(03)00312-5
Bledsoe, 2006, Kallikrein/kinin protects against gentamicin-nephro-toxicity by inhibition of inflammation and apoptosis, Nephrol Dial Transplant, 21, 624, 10.1093/ndt/gfi225
Priyamvada, 2008, Studies of the protective effect of dietary fish oil on gentamicin-induced nephrotoxicity and oxidative damage in rat kidney, Prostaglandin Leukot Essent Fatty Acids, 78, 369, 10.1016/j.plefa.2008.04.008
Wiernsperger, 2007, 50 years later: is metformin a vascular drug with antidiabetic properties?, Br J Diabetes Vasc Dis, 7, 204, 10.1177/14746514070070050201
Guigas, 2004, Metformin inhibits mitochondrial permeability transition and cell death: a pharmacological in vitro study, Biochem J, 382, 877, 10.1042/BJ20040885
El-Mir, 2008, Neuroprotective role of antidiabetic drug metformin against apoptotic cell death in primary cortical neurons, J Mol Neurosci, 34, 77, 10.1007/s12031-007-9002-1
Detaille, 2005, Metformin prevents high glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process, Diabetes, 54, 2179, 10.2337/diabetes.54.7.2179
1998, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), Lancet, 352, 837, 10.1016/S0140-6736(98)07019-6
Leverve, 2001, Role of substrates in the regulation of mitochondrial function in situ, IUBMB Life, 52, 221, 10.1080/15216540152846037
El-Mir, 2000, Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I, J Biol Chem, 275, 223, 10.1074/jbc.275.1.223
Batandier, 2004, Opening of the mitochondrial permeability transition pore induces reactive oxygen species production at the level of the respiratory chain complex I, J Biol Chem, 279, 17197, 10.1074/jbc.M310329200
Plotnikov, 2007, The role of mitochondria in oxidative and nitrosative stress during ischemia/reperfusion in the rat kidney, Kidney Int, 72, 1493, 10.1038/sj.ki.5002568
Ali, 2003, Agents ameliorating or augmenting experimental gentamicin nephrotoxicity: some recent research, Food Chem Toxicol, 41, 1447, 10.1016/S0278-6915(03)00186-8
Wilcock, 1994, Accumulation of metformin by tissues of the normal and diabetic mouse, Xenobiotica, 24, 49, 10.3109/00498259409043220
Faure, 1999, An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats, Diabetes, 48, 353, 10.2337/diabetes.48.2.353
Rösen, 2006, Metformin delays the manifestation of diabetes and vascular dysfunction in Goto–Kakizaki rats by reduction of mitochondrial oxidative stress, Diabetes Metab Res Rev, 22, 323, 10.1002/dmrr.623
Gilbert, 1989, Polyaspartic acid prevents experimental amino-glycoside nephrotoxicity, J Infect Dis, 159, 945, 10.1093/infdis/159.5.945
Kimura, 2005, Metformin is a superior substrate for renal organic cation transporter OCT-2 rather than hepatic OCT-1, Drug Metab Pharmacokinet, 20, 379, 10.2133/dmpk.20.379
Schmitz, 2002, Megalin deficiency offers protection from renal aminoglycoside accumulation, J Biol Chem, 277, 618, 10.1074/jbc.M109959200
Bernardi, 2006, The mitochondrial permeability transition from in vitro artefact to disease target, FEBS J, 273, 2077, 10.1111/j.1742-4658.2006.05213.x
Dumas, 2009, Effect of transient and permanent permeability transition pore opening on NAD(P)H localization in intact cells, J Biol Chem, 284, 15117, 10.1074/jbc.M900926200
Batandier, 2006, The ROS production induced by a reverse-electron flux at respiratory chain complex I is hampered by metformin, J Biomembr Bioenerg, 38, 33, 10.1007/s10863-006-9003-8
Hardie, 2006, AMP-activated protein kinase – development of the energy sensor concept, J Physiol, 574, 7, 10.1113/jphysiol.2006.108944
Lee, 2007, A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy, Am J Physiol Renal Physiol, 292, P617, 10.1152/ajprenal.00278.2006
de Mattos, 2000, Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future, Am J Kidney Dis, 35, 333, 10.1016/S0272-6386(00)70348-9
Koyner, 2008, Antioxidants. Do have a place in the prevention or therapy of acute kidney injury?, Nephron Exp Nephrol, 109, 109, 10.1159/000142935
Salpeter, 2006, Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus, Cochrane Database Syst Rev, 25, CD002967
Barthelmebs, 2003, Mild acute renal failure potentiates metformin accumulation in the diabetic rat kidney without further impairment of renal function, Diabetes Metab, 29, 163, 10.1016/S1262-3636(07)70024-1
Holstein, 2005, Contraindications can damage your health. Is metformin a case in point?, Diabetologia, 48, 2454, 10.1007/s00125-005-0026-1
Mihara, 1978, Determination of malonaldehyde precursor in tissues by thiobarbituric acid test, Anal Biochem, 86, 271, 10.1016/0003-2697(78)90342-1
Santos, 2002, Determination of amikacin in biological tissues by HPLC, J Liq Chromatogh Rel Technol, 25, 463, 10.1081/JLC-120008760
Vincent, 2004, Sulfite-mediated oxidative stress in kidney cells, Kidney Int, 65, 393, 10.1111/j.1523-1755.2004.00391.x